Characterization of behavioral changes in T-maze alternation from dopamine D1 agonists with different receptor coupling mechanisms

Psychopharmacology (Berl). 2023 Oct;240(10):2187-2199. doi: 10.1007/s00213-023-06440-5. Epub 2023 Aug 14.

Abstract

Rationale: Dopamine D1 receptor agonists have been shown to improve working memory, but often have a non-monotonic (inverted-U) dose-response curve. One hypothesis is that this may reflect dose-dependent differential engagement of D1 signaling pathways, a mechanism termed functional selectivity or signaling bias.

Objectives and methods: To test this hypothesis, we compared two D1 ligands with different signaling biases in a rodent T-maze alternation task. Both tested ligands (2-methyldihydrexidine and CY208243) have high intrinsic activity at cAMP signaling, but the former also has markedly higher intrinsic activity at D1-mediated recruitment of β-arrestin. The spatial working memory was assessed via the alternation behavior in the T-maze where the alternate choice rate quantified the quality of the memory and the duration prior to making a choice represented the decision latency.

Results: Both D1 drugs changed the alternate rate and the choice latency in a dose-dependent manner, albeit with important differences. 2-Methyldihydrexidine was somewhat less potent but caused a more homogeneous improvement than CY208243 in spatial working memory. The maximum changes in the alternate rate and the choice latency tended to occur at different doses for both drugs.

Conclusions: These data suggest that D1 signaling bias in these two pathways (cAMP vs β-arrestin) has complex effects on cognitive processes as assessed by T-maze alternation. Understanding these mechanisms should allow the identification or discovery of D1 agonists that can provide superior cognitive enhancement.

Keywords: Dopamine D1 agonist; Functional selectivity/signaling bias; Rodent T-maze alternation; Spatial working memory.

MeSH terms

  • Dopamine Agonists* / pharmacology
  • Dopamine* / pharmacology
  • Ligands
  • Maze Learning
  • Receptors, Dopamine D1 / metabolism
  • beta-Arrestins / metabolism
  • beta-Arrestins / pharmacology

Substances

  • Dopamine Agonists
  • Dopamine
  • Ligands
  • Receptors, Dopamine D1
  • beta-Arrestins